POET Technologies Raises $400M at a Premium, Then Sees Stock Plunge 22% as Dilution Fears Bite

POET Technologies has pulled off a blockbuster capital raise — $400 million from a single institutional investor — but the optics are now anything but bullish. The stock slumped more than 22% on the day the deal closed, a stark reminder that even a well-priced equity placement can rattle shareholders when the dilution is this deep.

The Canadian photonics specialist sold roughly 19 million common shares at $21.00 apiece to MMCAP International, a premium over the Nasdaq closing price of $20.57 on May 14. Each share was bundled with a warrant exercisable at $26.25 over three years — a 25% premium to the issue price. Net proceeds from the registered direct placement came to approximately $399.7 million. Yet by the closing bell on May 18, the stock had tumbled to $15.97, well below the offering price. Year-to-date, the shares still cling to a gain of about 120%.

MMCAP’s participation stands out not only for its size but for the investor’s recent trading pattern. The same institution had been trimming its POET stake aggressively during the first quarter. Meanwhile, hedge fund Citadel, known for its sophisticated positioning, took the opposite tack and built up its holding over the same period.

CEO Suresh Venkatesan has laid out an ambitious roadmap for the fresh cash. The company intends to roughly tenfold its wafer production and optical engine assembly capacity by 2027, underpinned by a new agreement with partner Lumilens. To get there, POET is tripling its lab space in Singapore and constructing a large assembly plant in Malaysia. The workforce has already expanded to more than 115 employees globally, and the company is actively scouting for acquisitions and investing in light-source development.

Should investors sell immediately? Or is it worth buying POET Technologies?

Those expansion plans come as the executive suite undergoes a shuffle. CFO Thomas Mika has announced his departure, with a successor search underway. Sandeep Kumar steps in as the new chief operating officer, tasked with steering the production scale-up. The company’s core product — the optical interposer — integrates electronic and photonic components on a single chip, promising to replace conventional assembly and alignment processes in AI data center interconnect. POET is banking on that technology to convert a $400 million war chest into real revenue.

The financial position has certainly improved. POET now sits on about $375 million in cash, a necessary cushion after posting a net loss of roughly $43 million in the fourth quarter of 2025. Yet the improvement t revenue is still elusive, and skeptics question whether the company can translate its AI data center momentum into sales fast enough to offset the heavy share count increase from 19 million new shares plus the same number of potential warrants.

Beyond dilution and near-term profitability, a legal cloud is gathering. A group of shareholders is organizing a class-action suit, alleging that POET made misleading statements about its tax status and failed to disclose certain contract cancellations. Affected investors have until June 29, 2026, to join the action.

POET Technologies at a turning point? This analysis reveals what investors need to know now.

The capital is now in the bank, but execution remains the wild card. POET’s production targets, management changes, and legal exposures will be tested against concrete output and order numbers — not PowerPoint slides.

Ad

POET Technologies Stock: New Analysis - 19 May

Fresh POET Technologies information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated POET Technologies analysis...

en | CA73044W3021 | POET | boerse | 69374953 |